China: In vitro CRISPR in a patient with lung cancer: immune cells were edited to deactivate a gene (PD-1) that blocks the immune response to tumor cells, and then transplanted back into the patient’s body with the aim of eradicating the tumor. Post navigation Previous Article Previous Article September 14, 2016 Next Article Next Article September 15, 2016
